Company Filing History:
Years Active: 2010
Title: Hanqing Xie: Innovator in Biomedical Research
Introduction
Hanqing Xie is a prominent inventor based in Lambertville, NJ (US). He has made significant contributions to the field of biomedical research, particularly in the development of novel therapeutic approaches.
Latest Patents
Hanqing Xie holds 2 patents that showcase his innovative work. His latest patents include "Human thrombospondin polypeptide - A human thrombospondin 1 protein, polynucleotide encoding the protein, and pharmaceutical composition thereof." This patent focuses on a human thrombospondin 1 protein and its potential applications in medicine. Another notable patent is "Hepatocyte growth factor receptor splice variants and methods of using same." This invention provides novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor, along with methods and pharmaceutical compositions for treating various disorders such as cancer and immunological-related conditions.
Career Highlights
Hanqing Xie is currently associated with Compugen Ltd. Corporation, where he continues to advance his research and development efforts. His work has been instrumental in exploring new therapeutic avenues and enhancing our understanding of complex biological processes.
Collaborations
Some of his notable coworkers include Liat Mintz and Dvir Dahary, who contribute to the collaborative environment that fosters innovation and discovery.
Conclusion
Hanqing Xie's contributions to biomedical research through his patents and work at Compugen Ltd. Corporation highlight his role as a key innovator in the field. His ongoing research promises to impact the treatment of various medical conditions significantly.